OTUD6B governs cardiomyocyte cell-cycle progression and ventricular chamber development

The heart is the first organ to begin its work in a developing embryo, beating to pump blood long before the lungs draw their first breath or the brain forms its first thoughts. For this tiny engine to grow into a powerful pump capable of sustaining life, its muscle cells must divide rapidly and in perfect coordination. This process is tightly controlled by a complex system of molecular switches that tell cells when to grow, when to stop, and when to specialize. One of the most important ways cells manage these switches is through a tagging system called ubiquitination. Imagine a cell as a busy factory where proteins are the workers; sometimes a worker needs to be removed or recycled, and the cell attaches a small tag to mark it for disposal. Other times, a tag is removed to keep a worker active. The enzymes that perform this removal are called deubiquitinases, and they act as the factory's managers, deciding which proteins stay and which go. While scientists have long known that these managers are vital for keeping cells healthy, their specific role in building a heart from scratch has remained a mystery.

A team of researchers at Augusta University and Guangzhou Medical University has now uncovered a critical piece of this puzzle. They focused on a specific manager protein called OTUD6B, which had been linked to a rare human syndrome involving developmental delays and heart defects, but whose exact job in the heart was unknown. By creating special mouse models that lacked this protein, the scientists discovered that OTUD6B is essential for the heart to grow large enough to function. Without it, the heart muscle fails to thicken properly, leaving the chambers too thin and weak to pump blood effectively. The study reveals that OTUD6B works by keeping the cell division machinery running smoothly, ensuring that heart muscle cells can multiply at the right speed to build a robust ventricle.

The researchers began by investigating what happens when the amount of OTUD6B is slightly reduced versus when it is completely removed. They first examined mice that carried a genetic change reducing the protein levels to about ten percent of normal. These mice, which still possessed a small amount of the protein, grew up normally with healthy hearts and lived full lifespans. This finding was significant because it showed that the heart can tolerate a significant drop in this protein without immediate failure. However, when the researchers created mice with absolutely no OTUD6B at all, the results were starkly different. These embryos grew slowly and died shortly after birth, unable to survive even a few hours outside the womb. Upon closer inspection, their hearts were severely underdeveloped, with walls that were dangerously thin and a missing partition between the left and right sides, a defect known as a ventricular septal defect. The lungs were also collapsed, suggesting the newborns could not breathe effectively, likely due to the heart's inability to support circulation.

To understand why the hearts failed, the team looked at the genetic activity inside the developing hearts of the mice lacking OTUD6B. They found that the cells were struggling to follow the correct instructions for division. In a healthy heart, muscle cells divide rapidly to build up the thick walls of the ventricles. In the defective hearts, the cells started the process of copying their DNA but then got stuck, unable to finish the job. The researchers observed that the levels of key proteins required for cell division, such as Cyclin D3 and Cyclin E1, were drastically lower than normal. These proteins act as the fuel for the cell cycle, driving the cell from one stage of growth to the next. Without them, the cells accumulated in a state of stasis, unable to complete the cycle and multiply. This lack of multiplication meant the heart muscle never gained the necessary thickness, leading to a heart that was too weak to sustain life.

The team also wanted to know if these findings applied to humans, given that people with mutations in the OTUD6B gene often suffer from similar heart defects. They created a new line of mice carrying a specific genetic error found in patients, known as the R116* mutation. These mice behaved exactly like the ones with no OTUD6B at all. They suffered from the same thin heart walls, the same missing heart partitions, and the same tragic outcome of dying shortly after birth. This confirmed that the human mutation causes the same biological breakdown as a complete lack of the protein, providing a direct link between the genetic error and the physical heart defects seen in patients.

Further experiments showed that this problem was intrinsic to the heart muscle cells themselves. When the researchers removed the gene from heart cells grown in a dish, those cells also failed to divide properly and stopped producing the necessary division proteins. This proved that OTUD6B acts directly within the heart muscle to regulate its growth, rather than relying on signals from other parts of the body. The study also noted that while the heart was severely affected, the lungs showed signs of trouble only after birth, suggesting that the primary cause of death was the heart's inability to pump, which then prevented the lungs from inflating correctly.

This research establishes OTUD6B as a vital guardian of heart development, one of the few known enzymes that is indispensable for building a mammalian heart. It clarifies that the heart does not just need the right genes to start forming; it needs the right management systems to ensure those genes execute the rapid cell division required to build a functional organ. The findings explain why individuals with specific mutations in this gene are born with severe heart defects and provide a clear biological mechanism for their condition. By showing how the loss of a single protein disrupts the cell cycle and leads to a heart that cannot grow strong enough to survive, the study offers a new understanding of the molecular foundations of congenital heart disease. It highlights that the ubiquitin system, often studied in the context of cancer or aging, is also a fundamental architect of life, shaping the very first organ that keeps us alive.